A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1
EBRAINS is a new digital research infrastructure, created by the EU-funded Human Brain Project, which brings together a wide range of data and tools1
The activity is part of a new project of the institution to publicize the research done by IDIBAPS to patients and patient associations.
Intestinal microbiota performs essential functions in our body but can sometimes be damaged by taking antibiotics, or certain treatments such as chem1
The results of the study, carried out by researchers from Hospital Clínic-IDIBAPS and CIBERES, will make it possible to design new therapies for chro1
Regenerating and protecting pancreatic beta cells, which are responsible for producing and secreting insulin, are two of the areas of research being1
Treatment with gene therapy, however, reverses the damage caused by deposits of α-synuclein in the neuron circuits and alleviates neuropsychiatric sy1
The document establishes the basis for the exploitation and development of patented technology, owned by six research centers, including IDIBAPS.
Early diagnosis, a protein-free diet and treatment with a cofactor called BH4 make it possible for patients with this disease to develop normally. A1
SARS-CoV-2-induced lung injury can produce epithelial and endothelial lung damage half a year after hospital discharge, especially in patients old1